Zusammenfassung
Die vorliegenden Leitlinien zur Implantation von Defibrillatoren wurden in Überarbeitung der Leitlinien der Deutschen Gesellschaft für Kardiologie, Herz und Kreislaufforschung, wie sie 1993 publiziert worden sind, erstellt, basierend auf einer sorgfältigen Analyse der wissenschaftlichen Daten zur aktuellen Therapie ventrikulärer Tachyarrhythmien. Auch in Zukunft sollen diese Leitlinien in regelmäßigen Abständen revidiert werden, wenn der wissenschaftliche Erkenntnisstand dies erforderlich macht.
Die Leitlinien der Deutschen Gesellschaft für Kardiologie werden ständig von der klinischen Kommission auf ihre Aktualität überprüft.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Beihassen B, Viskin S (1993) Idiopathic ventricular tachycardia and fibrillation. J Cardiovasc Electrophysiol 4:356–368
Bigger JT, for the Coronary Artery Bypass Graft (CABG) Patch Trial Investigators (1997) Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery. N Engl J Med 337:1569–1575
Böcker D, Block M, Isbruch F, Wietholt D, Hammel D, Borggrefe M, Breithardt G (1993) Do patients with an implantable defibrillator live longer? J Am Coll Cardiol 21:1638–1648
Böcker D, Block M, Isbruch F, Fastenrath C, Castrucci M, Hammel D, Scheid HH, Borggrefe M, Breithardt G (1995) Benefits of treatment with implantable cardioverter defibrillators in patients with stable ventricular tachycardia without cardiac arrest. Br Heart J 73:158–163
Böcker D, Haverkamp W, Block M, Borggrefe M, Breithardt G (1996) Comparison of d,l Sotalol and implantable defibrillators for treatment of sustained ventricular tachycardia of fibrillation in patients with coronary artery disease. Circulation 94:151–157
Böcker D, Bänsch D, Heinecke A, Weber M, Brunn J, Hammel D, Borggrefe M, Breithardt G, Block M (1998) Potential benefit from ICD therapy in patients with and without heart failure. Circulation 97:98:1636–1643
Brugada J, Brugada R, Brugada P (1998) Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structure heart disease. Circulation 97:547–560
Buxton A (1999) Ergebnisse der MUSTT-Studie. ACC 1999, New Orleans
Chen X, Shenasa M, Borggrefe M, Block M, Hindricks G, Martinez-Rubio A, Haverkamp W, Willems S, Böcker D, Mäkijärvi M, Breithardt G (1994) Role of programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and documented sustained ventricular tachyarrhythmias: Inducibility and prognostic value in 102 patients. Eur Heart J 15:76–82
Connolly SJ, Gent M, Roberts RS, Dorian P, Green MS, Klein GJ, Mitchell LB, Sheldon RS, Roy D (1993) Canadian Implantable Defibrillator Study (CIDS): Study design and organization. Am J Cardiol 72:103F–108F
Connolly SJ (1998) The Canadian Implantable Defibrillator Study. Presented at the American College of Cardiology 47th Annual Scientific: March 1998: Atlanta, USA
Crijns HJGM, Wiesfeld ACP, Posma Jl, Lie KI (1995) Favourable outcome in idiopathic ventricular fibrillation with treatment aimed at prevention of high sympathetic tone and suppression of inducible arrhythmias. Br Heart J 74:408–412
Fananapazir L, Epstein SE (1991) Hemodynamic and electrophysiologic evaluation of patients with hypertrophic cardiomyopathy surviving cardiac arrest. Am Coll Cardiol 67:280–287
Giorgberidze I, Saksena S, Krol RB, Munsif AN, Kolettis T, Mathew P, Varanasi S, Prakash A, Delfaut P, Lewis CB (1997) Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease. A prospective single-center study. Am J Cardiol 80:3F–9F
Gregoratos G, Cheitlin MD, Conill A, Epstein AE, Fellows C, Ferguson TB Jr., Freedman RA, Hlatky MA, Naccarelli GV, Saksena S, Schlant RC, Silka MJ (1998) ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmic devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol 31:1175–1209
Grimm M, Wieselthaler G, Avanessian R, Grimm G, Schmidinger H, Schreiner W, Podczeck A, Wolner E, Laufer G (1995) The impact of implantable cardioverter defibrillators on mortality among patients on the waiting list for heart transplantation. J Thorac Cardiovasc Surg 110:532–539
Groh WJ, Silka MJ, Oliver RP, Halperin BD, McAnulty JH, Kron J (1996) Use of implantable cardioverter-defibrillators in the congenital long QT syndrome. Am J Cardiol 78:703–706
Klein LS, Shih HT, Hackett FK, Zipes DP, Miles WM (1992) Radiofrequency catheter ablation of ventricular tachycardia in patients without structural heart disease. Circulation 85:1666–1674
Knight BP, Strickberger SA, Daoud EG, Goyal R, Souza J, Zivin A, Morady F (1997) Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable cardioverter defibrillator. Circulation 96(Suppl):I-708
Kuck KH (1998) The Cardiac Arrest Study Hamburg. Presented at the American College of Cardiology 47th Annual Scientific: March 1998: Atlanta, USA
Kuck KH (1998) The Cardiomyopathy Trial. Presented at the German Society of Cardiology 63th Annual Scientific: April 1998: Mannheim, Germany
Levine JH, Waller T, Hoch D, Greenberg S, Goldberger J, Kadish A (1996) Implantable cardioverter defibrillator: use in patients with no symptoms and at high risk. Am Heart J 131:59–65
Link MS, Costeas XF, Griffith JL, Colburn CD, Estes III NAM, Wang PJ (1997) High incidence of appropriate implantable cardioverter defibrillator therapy in patients with syncope of unknown etiology and inducible ventricular arrhythmias. J Am Coll Cardiol 29:370–375
Meissner MD, Lehmann MH, Steinmann RT, Mosteller RD, Akhtar M, Calkins H, Cannom DS, Epstein AE, Fogoros RN, Liem LB, Marchlinski FE, Myerburg RJ, Veltri EP (1993) Ventricular fibrillation in patients without significant structural heart disease: A multicenter experience with implantable cardioverter-defibrillator therapy. J Am Coll Cardiol 21:1406–1412
Mewis C, Kühlkamp V, Spyridopoulos I, Bosch RF, Seipel L (1998) Late outcome of survivors of idiopathic ventricular fibrillation. Am J Cardiol 81:999–1003
Militianu A, Salacata A, Seibert K, Kehoe R, Baga JJ, Meissner MD, Pires LA, Schuger CD, Steinman RT, Mosteller RD, Palti AJ, David JB, Lessmeier TJ, Lehmann MH (1997) Implantable cardioverter defibrillator utilization among device recipients presenting exclusively with syncope or near-syncope. J Cardiovasc Electrophysiol 8:1087–1097
Mirowski M, Reid PR, Winkle RA, Mower MA, Watkins L, Stinson EB, Griffith LSC, Kallman CH, Weisfeldt ML (1983) Mortality in patients with implanted automatic defibrillators. Ann Int Med 98:585–588
Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M, for the Multicenter Automatic Defibrillator Implantation Trial Investigators (1996) Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335:1933–1940
Osswald S, Trouton TG, O’Nunain SS, Roelke M, Powell AC, Sosa-Suarez GE, McGovern BA, Garan H, Cannom DS, Ruskin JN (1996) Impact of the implantable cardioverter-defibrillator on long-term outcome in survivors of out-of-hospital cardiac arrest with idiopathic dilated cardiomyopathy. Eur J Card Pacing Electrophysiol 6:148–154
Powell AC, Fuchs T, Finkelstein DM, Garan H, Cannom DS, McGovern BA, Kelly E, Vlahakes GJ, Torchiana DF, Ruskin JN (1993) Influence of implantable cardioverter defibrillators on the long term prognosis of survivors of out of hospital cardiac arrest. Circulation 88:1083–1092
Priori SG, Paganini V, Boccalatte L, Schwartz PJ (1995) Idiopathic ventricular fibrillation: From anecdotal reports to a prospective evaluation. G Ital Cardiol 25:149–158
Primo J, Geelen P, Brugada J, Filho AL, Mont L, Wellens F, Valentino M, Brugada P (1998) Hypertrophic cardiomyopathy: Role of the implantable defibrillator. J Am Coll Cardiol 31:1081–1085
Schneider MAE, Siebels J, Rüppel R, Kuck KH, and the CASH Investigators (1993) Idiopathic ventricular fibrillation: Risk stratification and 24 months follow up in 16 patients. PACE 16:949
Siebels J, Kuck KH (1994) Implantable cardioverter defibrillator compared with antiarrhythmic drug treatment in cardiac arrest survivors (the Cardiac Arrest Study Hamburg). Am Heart J 127:1139–1144
Silka MJ, Kron J, Dunnigan A, Dick M II (1993) Sudden cardiac death and the use of implantable cardioverter defibrillators in pediatric patients. Circulation 87:800–807
Sweeney MO, Ruskin JN, Garan H, Mc-Govern BA, Guy ML, Torchiana DF, Vlahakes GJ, Newell JB, Semigran MJ, Dee GW (1995) Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation. Circulation 92:3273–3281
The Cardiomyopathy Trial Investigators (1993) Cardiomyopathy Trial. PACE 16(Pt II):576–581
The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators (1997) A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near fatal ventricular arrhythmias. N Engl J Med 337:1576–1583
Tsai CF, Chen SA, Tai CT, Chiang CE, Ding YA, Chang MS (1998) Idiopathic ventricular fibrillation: clinical, electrophysiologic characteristics and long-term outcomes. Int J Cardiol 64:47–55
Wever EF, Hauer RN, Oomen A, Peters RH, Bakker PF, Robles de Medina EO (1993) Unfavorable outcome in patients with primary electrical disease who survived an episode of ventricular fibrillation. Circulation 88:1021–1029
Wever EFD, Hauer RNW, van Capelle FJL, Tijssen JGP, Crijns HJGM, Algra A, Wiesfeld ACP, Bakker PFA, Robles de Medina EO (1995) Randomized study of implantable defibrillator as first choice therapy versus conventional strategy in postinfarct sudden death survivors. Circulation 91:2195–2203
Wichter T,_ Breithardt G, Block M, Haverkamp W, Borggrefe M (1994) Management of patients with arrhythmogenic right ventricular cardiomyopathy — results in 127 patients. New Trends in Arrhythmias 9:749–755
Wichter T, Borggrefe M, Block M, Oen H, Böcker D, Breithardt G (1996) Implantable cardioverter-defibrillator therapy improves long-term prognosis of patients with idiopathic ventricular fibrillation. Eur Heart J 17(Suppl):504
Zhu DW, Sun H, Hill R, Roberts R (1998) The value of electrophysiology study and prophylactic implantation of cardioverter defibrillator in patients with hypertrophic cardiomyopathy. PACE 21:291–302
Literatur
Jung W, Lüderitz B. (1996) Quality of life and driving in recipients of the implantable cardioverter-defibrillator. Am J Cardiol 78:51–56
Jung W, Deister A, Grädtz S, Manz M, Lüderitz B. (1995) Lebensqualität und psychosoziale Probleme bei der Betreuung von Patienten mit implantierbarem Kardioverter-Defibrillator. Herzschr Elektrophys 6(Suppl l):21–28
Jung W, Lüderitz B. (1996) Driving and the implantable cardioverter defibrillator. Lancet 348:687–688
Bänsch D, Brunn J, Castrucci M, Weber M, Gietzen F, Borggrefe M, Breithardt G, Block M. (1998) Syncope in patients with an implantable cardioverter-defibrillator: incidence, prediction and implications for driving restrictions. J Am Coll Cardiol 31:608–615
Jung W, Lüderitz B. (1996) European policy on driving for patients with implantable cardioverter-defibrillators. PACE 19:981–984
Schriftenreihe des Bundesministeriums für Verkehr: Krankheit und Kraftverkehr. Gutachten des Gemeinsamen Beirates für Verkehrsmedizin. 1996; Heft 73
Jung W, Anderson M, Camm J, Jordaens L, Petch M, Rosenqvist M, Santini M, Lüderitz B. (1997) Recommendations for driving of patients with implantable cardioverter defibrillators. Eur Heart J 18:1210–1219
Epstein AE, Miles WM, Benditt DG, et al (1996) Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations. A medical/ scientific statement from the AHA and the NASPE. Circulation 94:1147–1166
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hohnloser, S.H. et al. (2001). Leitlinien zur Implantation von Defibrillatoren. In: Trappe, HJ., Schuster, HP. (eds) Die Notfalltherapie bei akuten Herzrhythmusstörungen. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57631-7_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-57631-7_8
Publisher Name: Steinkopff, Heidelberg
Print ISBN: 978-3-7985-1294-8
Online ISBN: 978-3-642-57631-7
eBook Packages: Springer Book Archive